Study Name: Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes
21 locations found
- Pfizer Investigational Site
Location: Belleview, Florida 34420
- Pfizer Investigational Site
Location: Miami, Florida 33135
- Pfizer Investigational Site
Location: Ocala, Florida 34471
- Pfizer Investigational Site
Location: Conyers, Georgia 30094
- Pfizer Investigational Site
Location: Mount Sterling, Kentucky 40353
- Pfizer Investigational Site
Location: Paramus, New Jersey 07652
- Pfizer Investigational Site
Location: Rochester, New York 14609
- Pfizer Investigational Site
Location: Kettering, Ohio 45429
- Pfizer Investigational Site
Location: Charleston, South Carolina 29407
- Pfizer Investigational Site
Location: Anaheim, California 92801
- Pfizer Investigational Site
Location: Los Angeles, California 90057
- Pfizer Investigational Site
Location: Spring Valley, California 91978
- Pfizer Investigational Site
Location: Meridian, Idaho 83646
- Pfizer Investigational Site
Location: Las Vegas, Nevada 89144
- Pfizer Investigational Site
Location: Fargo, North Dakota 58103
- Pfizer Investigational Site
Location: Oklahoma City, Oklahoma 73112
- Pfizer Investigational Site
Location: Austin, Texas 78756
- Pfizer Investigational Site
Location: Houston, Texas 77081
- Pfizer Investigational Site
Location: Plano, Texas 75024
- Pfizer Investigational Site
Location: Sugar Land, Texas 77479
- Pfizer Investigational Site
Location: Tomball, Texas 77375
|